Magnetar Financial’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Magnetar Financial’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-829,531	Closed	-$56.5M	–	1505
2022 Q3	$56.5M	Buy	+829,531	New	+$45.7M	0.78%	23
2020 Q2	–	Sell	-8,623	Closed	-$441K	–	609
2020 Q1	$441K	Buy	8,623 +5,538	+180%	+$371K	0.01%	294
2019 Q4	$245K	Buy	+3,085	New	+$183K	0.01%	475
2019 Q3	–	Sell	-30,000	Closed	-$1.58M	–	603
2019 Q2	$1.58M	Buy	+30,000	New	+$1.72M	0.03%	137

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Magnetar Financial's GBT Position: Q4 2022 in Review

Magnetar Financial sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 829,531 shares — an estimated $56.5M sold.

Magnetar Financial first reported a position in GBT in Q2 2019 and held it in 4 quarters. The position peaked at $56.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

Magnetar Financial reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
Magnetar Financial sold 829,531 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $56.5M.
Magnetar Financial first reported a position in Global Blood Therapeutics, Inc. in Q2 2019 and held it in 4 quarters.
Magnetar Financial's Global Blood Therapeutics, Inc. position peaked at $56.5M in Q3 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Magnetar Financial's 13F filing for Q4 2022, filed 14 Feb 2023.